[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![investseekers Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1477615559252586500.png) Investseekers [@investseekers](/creator/twitter/investseekers) on x 2640 followers
Created: 2025-07-21 11:10:15 UTC

$ALKB just received a positive recommendation from NICE, the UK’s health authority,  for its birch pollen allergy tablet, Itulazax. It’s the second such endorsement this year, following one for its dust mite tablet, Acarizax.

With this, ALK-Abello becomes the only provider of sublingual allergy treatments approved for use in the UK’s public healthcare system (NHS).

Unfortunately, it’s also one of those great companies that always trades at too high a valuation for my taste.

#StocksInFocus #Investing


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1947252778054606917/c:line.svg)

**Related Topics**
[coins healthcare](/topic/coins-healthcare)
[pollen](/topic/pollen)
[birch](/topic/birch)
[$alkb](/topic/$alkb)

[Post Link](https://x.com/investseekers/status/1947252778054606917)